BE OPEN has received an observer status to the United Nations Environment Programme after making an application describing the multi-year educational programme dedicated to the Sustainable Development Goals. This accreditation marks the achievement of an important stage in BE OPEN's progress in supporting creative approaches to various areas of human activity, in order to achieve […]
(NasdaqGM:WRD),(HKSE: 0800.HK),(HKSE: 0800-HK),(NASDAQ:^HXC), NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD, HKEX:0800), a global leader in autonomous driving technology, today announced its unaudited financial results for the three months ended September 30, 2025. Financial and Operational Highlights Total revenue grew 144.3% year-over-year (YoY) to RMB171.0 million (US$24.0
DUBAI, United Arab Emirates, Nov. 24, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) is entering one of its most defining moments, with Phase 6 now 90% sold out as the project moves closer to its Q4 2025 V1 protocol launch. Interest in the presale has accelerated as the team continues to release updates on development,
(TSX-V:RKV),(Boerse Frankfurt – Freiverkehr:7JO0), VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced impressive results from its AI-enabled ATR program at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting which took place November
(TSX-V:WHN),(TSX-V:WHN.V), VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V: WHN) (“Westhaven” or the “Company“) is pleased to announce the completion of an upsized summer drilling program as part of the Company's ongoing evaluation of its 100%-owned Shovelnose Gold Project (“Shovelnose“) located within southern British Columbia's Spences Bridge Gold Belt (“SBGB“).
(NASDAQ:GNTA), MILAN, Italy and NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — Genenta Science (Nasdaq: GNTA), a clinical-stage biotechnology company developing a cell-based platform for targeted delivery of therapeutic payloads in oncology, today announced an update from its ongoing TEM-GBM study in newly diagnosed glioblastoma multiforme (GBM) patients with an unmethylated MGMT (uMGMT) gene promoter.
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its October 27th Registered Direct Offering GlobeNewswire November 24, 2025 MILAN, Italy and NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — Genenta Science (Nasdaq: GNTA), a clinical-stage biotechnology company developing a
Global Expansion Accelerates: Landmark UAE Driverless Robotaxi Commercial Permit, Autonomous Vehicles Licensed in Eight Countries, Record YoY Revenue Growth of 144.3% WeRide Announces Unaudited Financial Results for Q3 2025 GlobeNewswire November 24, 2025 NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD, HKEX:0800), a global leader in autonomous
Mutuum Finance (MUTM) Phase 6 Is 90% Sold Out Ahead of Its Q4 2025 V1 Protocol Launch GlobeNewswire November 24, 2025 DUBAI, United Arab Emirates, Nov. 24, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) is entering one of its most defining moments, with Phase 6 now 90% sold out as the project moves closer to
Rakovina Therapeutics Showcases Compelling Preclinical Data on AI-Discovered CNS-Penetrant ATR/mTOR Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting Variational AI's Enki(TM) generative AI platform designed novel ATR/mTOR dual inhibitors with brain penetrance and activity in PTEN-deficient tumor models GlobeNewswire November 24, 2025 VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc.